MMJ Files Patent on Part-cannabinoid and Part-non-cannabinoid Treatment for MS
News
MMJ International Holdings is seeking a patent for a part-cannabinoid and part-non-cannabinoid treatment for multiple sclerosis and other diseases. The company said in a news release that it filed the patent ... Read more